Skip to content
healthcare.dev

Everolimus

NDC 70377-069, Everolimus, tablet, from Biocon Pharma Inc..

Product NDC
70377-069
Status
Listed
Labeler
Biocon Pharma Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA216140
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70377-069 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EVEROLIMUS.25 mg/1

Pharmacologic classes

Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Immunologic Activity [PE]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]; mTOR Inhibitor Immunosuppressant [EPC]; mTOR Inhibitors [MoA]

Package NDCNDC-11Package
70377-069-117037700691160 TABLET in 1 BOTTLE (70377-069-11)
70377-069-12703770069126 BLISTER PACK in 1 CARTON (70377-069-12) / 10 TABLET in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/435da284-ef0e-ca90-e0db-bab9382922e0
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=70377-069
  • NADAC price for package 70377006911

    GET /v1/drugs/nadac/70377006911

Use it

Look up 70377-069 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70377-069 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70377-069. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.